A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation

Transplantation

Volumn 66, Issue 12, 1998, Pages 1751-1759

  Odorico, Jon S ^a   Pirsch, John D ^a   Knechtle, Stuart J ^a   D'Alessandro, Anthony M ^a   Sollinger, Hans W ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL PROTOCOL; DRUG RESISTANCE; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INFECTION;

ACUTE DISEASE; ADULT; AZATHIOPRINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; OPPORTUNISTIC INFECTIONS; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032573739     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00032     Document Type: Article

References (36)

1. Mitsui A, Suzuki S. Immunosuppressive effect of mycophenolic acid. J Antibiot 1969; 22: 358.
2. Allison AC, Eugui EM. Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transplant 1993; 7: 96.
3. Young CJ, Sollinger H. Mycophenolate mofetil (RS-61443). In: Sollinger HW, Przepiorka D, eds. New immunosuppressive drugs. Glenview, IL: Physicians and Scientists Publishing, 1994; 93.
4. Nagai M, Natsumeda Y, Konno Y, Hoffman R, Irino S, Weber G. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res 1991; 51: 3886.
5. Konno Y, Natsumeda Y, Nagai M, et al. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J Biol Chem 1991; 266: 506.
6. Nagai M, Natsumeda Y, Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res 1992; 52: 258.
7. Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991; 33: 161.
8. Allison AC, Almquist SJ, Muller CD, Eugui EM. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 1991; 23: 10.
9. Dayton JS, Turka LA, Thompson CB, Mitchell BS. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 1992; 41: 671.
10. Senda M, DeLustro B, Eugui E, Natsumeda Y. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 1995; 60: 1143.
11. Laurent AF, Dumont S, Poindron P, Muller CD. Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 1996; 24: 59.
12. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.
13. Morris RE, Wang J, Blum JR, et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991; 23: 19.
14. Platz KP, Bechstein WO, Eckhoff DE, Suzuki Y, Sollinger HW. RS-61443 reverses acute allograft rejection in dogs. Surgery 1991; 110: 736.
15. Platz KP, Eckhoff DE, Hullett DA, Sollinger HW. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent. Transplant Proc 1991; 23: 497.
16. Knechtle SJ, Wang J, Burlingham WJ, Beeskau M, Subramanian R, Sollinger HW. The influence of RS-61443 on antibody-mediated rejection. Transplantation 1992; 53: 699.
17. Steele DM, Hullett DA, Bechstein WO, et al. Effects of immuno-suppressive therapy on the rat aortic allograft model. Transplant Proc 1993; 25: 754.
18. Nakajima K, Ochiai T, Nagata M, et al. Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. Transplant Proc 1993; 25: 595.
19. D'Alessandro AM, Rankin M, McVey J, et al. Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone. Transplantation 1993; 55: 695.
20. Shaffer D, Blakely ML, Gottschalk R, Monaco AP. Small bowel transplantation in rats using RS-61443: effect on GVHD and rejection. Transplant Proc 1992; 24: 1159.
21. Van den Helder TB, Benhaim P, Anthony JP, McCalmont TH, Mathes SJ. Efficacy of RS-61443 in reversing acute rejection in a rat model of hindlimb allotransplantation. Transplantation 1994; 57: 427.
22. Hao L, Calcinaro F, Gill RG, Eugui EM, Allison AC, Lafferty KJ. Facilitation of specific tolerance induction in adult mice by RS-61443. Transplantation 1992; 53: 590.
23. D'Alessandro AM, Rankin MA. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection. Transplant Proc 1994; 26: 1611.
24. O'Hair DP, McManus RP, Komorowski R. Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil. Ann Thorac Surg 1994; 58: 1311.
25. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225.
26. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
27. Groth CG. The European experience with mycophenolate mofetil: European Mycophenolate Mofetil Cooperative Study Group. Transplant Proc 1996; 28: 30.
28. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321.
29. Stratta RJ, Sollinger HW, Perlman SB, et al. Early diagnosis and treatment of pancreas allograft rejection. Transpl Int 1988; 1: 6.
30. Odorico JS, Rayhill SC, Heisey DM, et al. Immunologic risks of combined kidney-pancreas transplantation. Transplant Proc 1998; 30: 249.
31. Odorico JS, Sollinger HW. Pancreas transplantation. In: Schwartz SI, ed. Principles of surgery. New York: McGraw-Hill, 1998.
32. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Transplantation 1997; 64: 1695.
33. Elkhammas EA, Yilmaz S, Henry ML, et al. Combined kidney/ pancreas transplantation (KPT): comparison of mycophenolate mofetil (MMF) vs. azathioprine (AZA). Abstract presented at the American Society of Transplant Physicians 16th Annual Scientific Meeting, Chicago, IL, 1997.
34. Jain AB, Fung JJ, Hamd I, et al. Prospective randomized trial of tacrolimus and prednisone vs. tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplant recipients. Abstract presented at the American Society of Transplant Physicians 16th Annual Scientific Meeting, Chicago, IL, 1997.
35. Eckhoff DE, Ingram CO, Frennette L, Cox J, McGuire BM, Stevenson-Bynon J. Tacrolimus (FK506) and mycophenolate mofetil (MMF) combination therapy versus tacrolimus in adult liver transplantation. Abstract presented at the American Society of Transplant Physicians 16th Annual Scientific Meeting, Chicago, IL, 1997.
36. Costanzo MR. Results of the randomized trial of mycophenolate mofetil vs. azathioprine in heart transplantation. Abstract presented at the American Society of Transplant Physicians 16th Annual Scientific Meeting, Chicago, IL, 1997.